Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure.
- 1 July 1987
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 84 (13), 4577-4580
- https://doi.org/10.1073/pnas.84.13.4577
Abstract
An ideal treatment for autoimmune diseases would be a nontoxic means of specifically neutralizing the autoreactive lymphocytes responsible for the disease. This goal has been realized in experimental autoimmunity models by immunizing rats or mice against their own autoimmune cells such that the animals generate an immune response specifically repressive to the disease-producing lymphocytes. This maneuver, termed lymphocyte vaccination, was demonstrated to be effective using some, but not all, autoimmune helper T-lymphocyte lines. We now report that T lymphocytes, otherwise incapable of triggering an immune response, can be transformed into effective immunogens by treating the cells in vitro with hydrostatic pressure. Clone A2b, as effector clone that recognized cartilage proteoglycan and caused adjuvant arthritis in Lewis rats, is such a cell. Untreated A2b could not trigger an immune response, but inoculating rats with pressure-treated A2b induced early remission of established adjuvant arthritis as well as resistance to subsequent disease. Specific resistance to arthritis was associated with anti-idiotypic T-cell reactivity to clone A2b and could be transferred from vaccinated rats to naive recipients using donor lymphoid cells. Aggregation of T-lymphocyte membrane components appeared to be important for an immune response because the effects of hydrostatic pressure could be reproduced by treatment of A2b with chemical cross-linkers or with agents disrupting the cytoskeleton. Populations of lymph node cells from antigen-primed rats, when treated with hydrostatic pressure, could also induce suppression of disease. Thus, effective vaccines can be developed without having to isolate the autoimmune T lymphocytes as lines or clones. These results demonstrate that effector T lymphocytes suitably treated may serve as agents for specifically controlling the immune system.This publication has 20 references indexed in Scilit:
- Regulation of Autoimmune Disease Physiological and TherapeuticImmunological Reviews, 1986
- T LYMPHOCYTES OF RHEUMATOID ARTHRITIS PATIENTS SHOW AUGMENTED REACTIVITY TO A FRACTION OF MYCOBACTERIA CROSS-REACTIVE WITH CARTILAGEThe Lancet, 1986
- Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressureCancer Immunology, Immunotherapy, 1986
- Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.Proceedings of the National Academy of Sciences, 1985
- Role of the thymus in induction and transfer of vaccination against adjuvant arthritis with a T lymphocyte line in rats.JCI Insight, 1985
- Membrane fluidity in malignancy Adversative and recuperativeBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1984
- Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.JCI Insight, 1984
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981
- Experimental models in rheumatoid diseaseArthritis & Rheumatism, 1964